Direct compression Granules

Globela Pharma is one of the few companies present the pharmaceutical manufacturing
value chain of Pharmaceutical Formulation Intermediates (PFIs) (DC) to Finished Dosages
(FDs). We offer our customers all three components of the pharmaceutical manufacturing
value chain to enhance flexibility and efficiency.
We back our product lines with cGMP .WHO manufacturing infrastructure. To support our
Direct compression Granules facility we have strong back word Tie up with API
manufacturer for DMF and facility Like Ibuprofen , Metformin , Ciprofloxacin,
Metronidazole , Paracetamol . Facilities meet the stringent requirements of demanding
international regulatory authorities such as the WHO GMP ..
Direct Drum to Hopper product with Unique formula .
-Sustain released Direct compression granules Metformin SR suitable to 500 mg ,
850 mg & 1 gm Tablets
-Extended released
-Rapid released
-Test masking of formula for paediatric suspension
Pharmaceutical Formulation Intermediates (Direct Compression Granules ) -DC
What is a DC ?
DC is the intermediate product between an API and a Finished Dosage. The proposition that
DC could be outsourced as customer requirement without much technology risk at their end
they get ready granules with proven quality and data of stability to meet international
standard that transformed the conventional pharmaceutical manufacturing model by offering
customers significant savings, fewer handling hurdles and higher efficiency.
The Companys concept is based on a ready-to-compress mix of APIs and excipients that
can be fed directly into a compression machine to manufacture finished dosages - a single
step process.
Financial Benefits
Savings in capital expenditures and technical resources.
Lower testing costs
Increased asset utilisation
Save development cost and Proven Technology Back up
Operational Benefits Stability: Outsourcing DC from a dedicated specialist like us makes it
possible for products to retain their compression and other quality characteristics throughout
their shelf-life
Desired properties: leading to finished dosage manufacturers getting favourable outcomes
from their bioequivalence studies.

Dry Blending: We possess the capability for some PFIs to be dry-blended with other APIs
without the need for further granulation to obtain homogeneous mixtures.
Our Product Mixed
Single active: Paracetamol/Acetaminophen | Metformin HCl | Ibuprofen | Guaifenesin |
Methocarbamol | Ciprofloxacin
Multiple actives: Paracetamol and Chlorpheniramine Maleate | Paracetamol and
Diphenhydramine HCl | Ibuprofen and Pseudoephedrine HCl | Paracetamol and Caffeine
Product List Direct compression granules ( Ready for compress
tablets )
Name Of product
Packing
Self Life
50 KGS
36
CIPROFLOXACIN DC GRANULES 90 %
DRUM
MONTH
50 KGS
36
CIPROFLOXACIN DC GRANULES 65 %
DRUM
MONTH
50 KGS
36
IBUPROFEN DC GRANULES 95 %
DRUM
MONTH
50 KGS
36
IBUPROFEN DC GRANULES 90%
DRUM
MONTH
50 KGS
36
IBUPROFEN DC GRANULES 73%
DRUM
MONTH
50 KGS
36
IBUPROFEN DC GRANULES 66%
DRUM
MONTH
50 KGS
36
METFORMIN HYDROCHLORIDE DC 95%
DRUM
MONTH
50 KGS
36
METFORMIN HYDROCHLORIDE DC 90%
DRUM
MONTH
50 KGS
36
METFORMIN HYDROCHLORIDE DC 80 %
DRUM
MONTH
50 KGS
36
METRONIDAZOLE DC 90 %
DRUM
MONTH
50 KGS
36
METRONIDAZOLE DC 80 %
DRUM
MONTH
50 KGS
36
NAPROXEN DC 80 %
DRUM
MONTH
50 KGS
36
PARACETAMOL DC 95 %
DRUM
MONTH
50 KGS
36
PARACETAMOL DC 90 %
DRUM
MONTH
50 KGS
36
ASCORBIC ACID DC90 %
DRUM
MONTH
50 KGS
36
ASCORBIC ACID DC 97 % ( COATED )
DRUM
MONTH
50 KGS
36
ATENOLOL DC 90 %
DRUM
MONTH
50 KGS
36
TELMISARTAN 65% GRANULES
DRUM
MONTH
50 KGS
36
BETAHISTIN 8% DC
DRUM
MONTH
50 KGS
36
DICLOFENAC SODIUM DC
DRUM
MONTH